Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
196-210 of 362

Ongoing Clinical Trials in AML With Menin Inhibitors
MinuteCE®Ongoing Clinical Trials in AML With Menin Inhibitors

Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
MinuteCE®Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management

Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
MinuteCE®Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
- advertisement

Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
CME/CECommunity Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management

Managing Adverse Events Associated With Menin Inhibitors
MinuteCE®Managing Adverse Events Associated With Menin Inhibitors

Molecular Profiling as a Cornerstone of Precision AML Therapy
MinuteCE®Molecular Profiling as a Cornerstone of Precision AML Therapy

Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
CME/CEContrasting TROP2-Targeted ADCs in Breast Cancer Therapy

HER2 in Bladder Cancer: Breaking Through the Molecular Frontier
CME/CEHER2 in Bladder Cancer: Breaking Through the Molecular Frontier
- advertisement

Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
CME/CE Broadcast ReplayPulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer

Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer

Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics








































